What the Newly Published 2026 NCCN Guidelines Mean for Mesothelioma Patients
For someone diagnosed with pleural mesothelioma, treatment decisions can feel overwhelming. Surgery, chemotherapy, immunotherapy, radiation and clinical trials may all be discussed, and the best approach can vary considerably from one person to another. A major new update from the… Read More »
Read MoreBelluck Law Expands into Pennsylvania with New Philadelphia and Carlisle Offices
Northeast Go-To Mesothelioma Firm Names Bethann Kagan Pennsylvania Managing Partner as Firm Expands Local Presence PHILADELPHIA, PA — Today, Belluck Law, LLP, a nationally recognized mesothelioma and asbestos litigation firm, announced its expansion into Pennsylvania with the opening of new… Read More »
Read MoreRoadmap for Treating Pleural Mesothelioma: New Expert Consensus
A new expert consensus document by top mesothelioma experts on behalf of The Society of Thoracic Surgeons (STS), published in The Annals of Thoracic Surgery in 2026, provides the most up-to-date treatment recommendations based on a comprehensive review of the… Read More »
Read MoreEverything You Need to Know about the MARS2 Trial for Mesothelioma Surgery
A diagnosis of pleural mesothelioma brings with it a number of difficult decisions. One of the biggest questions many patients face is whether surgery should be part of their treatment. For years, surgery was considered an important option for carefully… Read More »
Read MoreChemotherapy Still Plays an Important Role After Immunotherapy Fails
A new real-world study from Germany offers encouraging news for people living with pleural mesothelioma, a rare and aggressive cancer that affects the lining of the lungs. Researchers found that a long-established chemotherapy combination remains an effective treatment option after… Read More »
Read MoreJoseph W. Belluck Re-Elected Chair of New York State Commission on Judicial Conduct
Joseph W. Belluck, founder of Belluck Law, has been unanimously re-elected Chair of the New York State Commission on Judicial Conduct, continuing a leadership role he has held since 2016. The Commission also unanimously re-elected Taa Grays as Vice Chair… Read More »
Read MorePIPAC for Peritoneal Mesothelioma: A Promising Treatment Under Investigation
Malignant peritoneal mesothelioma is a rare cancer that develops in the lining of the abdomen, known as the peritoneum. Although it accounts for only a small percentage of all mesothelioma cases, it can be difficult to diagnose and treat because… Read More »
Read MoreNew Study Shows Mesothelioma’s Burden Remains Significant
Mesothelioma is often described as a disease of the past, linked to an era when asbestos was widely used in shipyards, factories, construction sites and military equipment across the United States. Yet a new nationwide study suggests that the impact… Read More »
Read MoreAdvances and Controversies in Mesothelioma Treatment: Insights from Dr. Jeffrey Velotta
Mesothelioma remains one of the rarest and most complex cancers to treat, demanding highly specialized expertise and a coordinated, multidisciplinary approach. In a recent episode of Raise Plow, the podcast by Belluck Law, thoracic surgeon Dr. Jeffrey Velotta shared an… Read More »
Read MoreIs it ever appropriate to perform surgery on a patient with sarcomatoid mesothelioma?
Usually, the answer is almost always no. Sarcomatoid mesothelioma is one of the rarest and most aggressive cell types of mesothelioma, a cancer that develops on the lining of the lungs and stems from exposure to asbestos. Because of its… Read More »
Read More